Skip to main content

Renovacor, Inc.

RCORDelisted Dec 1, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001799850

Renovacor, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Apr 5, 2023; 27 institutions reported holding it in 13F filings for Q3 2022, worth $18.4M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Renovacor, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of RCOR: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders2223+1
Shares7.19M7.58M+391.4K (+5.4%)
Value$64.5M$58.4M−$6.15M (−9.5%)

New holders (5)

Institutions that held Renovacor, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to RCOR in Q4 2021
InstitutionSharesValue% of portfolio
Northern Trust Corp16,861$130.0K0.00%
Tower Research Capital LLC (TRC)1,020$8.00K0.00%
Wolverine Asset Management LLC930$7.00K0.00%
BlackRock Inc.617$5.00K0.00%
Wells Fargo & Company64$00.00%

Sold out (4)

Institutions that held Renovacor, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of RCOR in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Murchinson Ltd.25,000$226.0K
Susquehanna International Group, LLP10,521$95.0K
Cowen and Company, LLC10,000$91.0K
Bank of America Corp745$7.00K